Loading...
Uploaded by journeymnn on Apr 20, 2009
Molto J, et al. Pharmacokinetics and safety of once-daily raltegravir (800 mg) plus atazanavir (400 mg) in HIV-infected patients, presented at the 10th HIV Pharmacology Workshop, Amsterdam, April 15-17, 2009
Science & Technology
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)